Restricted isotypic antibody reactivity to hepatitis C virus synthetic peptides in immunocompromised patients

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 2, 1999, Pages 279-281

  Devesa, Marisol ^a   De Saez, Arlette ^b   León, Graciela ^b   Sirit, Firelei ^c   Cosson, Clarisa ^a   Bermúdez, Henry ^d   Liprandi, Ferdinando ^a   Noya, Oscar ^d   Pujol, Flor H ^a,e  

^a Lab de Biología de Virus   (Venezuela)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^c Planta Procesadora Derivados S   (Venezuela)

^d UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^e Instituto Venezolano de Investigaciones Cientificas Centro de Microbiologia y Biologia Celular   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE ANTIBODY; SYNTHETIC PEPTIDE;

ANTIBODY RESPONSE; ARTICLE; ENZYME IMMUNOASSAY; HEMODIALYSIS; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS DIAGNOSIS; VIRUS HEPATITIS;

EID: 0032979020     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.2.279-281.1999     Document Type: Article

References (25)

1. Antonace, S., E. Jirillo, D. Stassi, V. De Mitrio, M. F. La Via, and L. Bonomo. 1988. Immunoresponsiveness in hemophilia: lymphocyte- and phagocyte-mediated functions. Diagn. Clin. Immunol. 5:318-325.
2. Claeys, H., A. Volckaerts, W. Mertens, Z. Liang, P. Fiten, and G. Opdenakker. 1995. Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus. J. Med. Virol. 45:273-281.
3. Courouce, A.-M., N. Le Marrec, A. Girault, S. Ducamp, and N. Simon. 1994. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays. Transfusion 34:790-795.
4. Courouce, A.-M., F. Barin, C. Botté, F. Lunel, P. Maisonneuve, M. Maniez, and C. Trépo. 1995. A comparative evaluation of the sensitivity of seven anti-hepatitis C virus screening tests. Vox Sang. 69:213-216.
5. Devesa, M., Y. E. Khudyakov, F. Capriles, L. Blitz, H. A. Fields, F. Liprandi, and F. H. Pujol. 1997. Reduced antibody reactivity to hepatitis C virus antigens in hemodialysis patients coinfected with hepatitis B virus. Clin. Diagn. Lab. Immunol. 4:639-642.
6. Gabrielli, A., Z.-X. Zhang, G. Cherubi, M. Candela, S. Savoldi, A. Manzin, M. Clementi, A. Amoroso, and M. Sällberg. 1996. Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia. Clin. Exp. Immunol. 105:59-64.
7. Goldblum, S. E., and W. P. Reed. 1980. Host defenses and immunological alterations associated with chronic hemodialysis. Ann. Intern. Med. 93:597-613.
8. Hosein, B., C. T. Fang, M. A. Popovsky, J. Ye, M. Zhang, and C. Y. Wang. 1991. Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc. Natl. Acad. Sci. USA 88:3647-3651.
9. Houghton, R. A. 1985. Simultaneous multiple peptide synthesis. Proc. Natl. Acad. Sci. USA 82:5131-5135.
10. Khudyakov, Y. E., N. S. Khudyakova, D. L. Jue, S. B. Lambert, S. Fang, and H. A. Fields. 1995. Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides. Virology 206:666-672.
11. Logombardo, G., C. Ferri, S. Marchi, F. Costa, F. Lombardini, L. Vacri, S. Bombardieri, and P. Migliorini. 1998. Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders. Clin. Immunol. Immunopathol. 87:124-129.
12. Meijer, K., W. M. Smid, S. P. Verspiek, J. W. Smit, and J. van der Meer. 1998. Differences in immune response between HCV positive, HIV negative haemophilia A and B patients. Thromb. Haemostasis 79:59-61.
13. Merrifield, R. B. 1963. Solid-phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:2149-2154.
14. Mizokami, M., T. Shin-I, and T. Gojobori. 1997. HCV data base, version 1. National Institute of Genetics, Mishima, Japan.
15. Patarroyo, M. E., R. Amador, P. Clavijo, A. Moreno, F. Guzmán, P. Romero, R. Tascón, A. Franco, L. Murillo, G. Pontón, and G. Trujillo. 1988. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature 332:158-161.
16. Pujol, F. H., J. G. Ponce, M. G. Lema, F. Capriles, M. Devesa, F. Sirit, M. Salazar, G. Vásquez, F. Monsalve, and L. Blitz-Dorfman. 1996. High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence. J. Clin. Microbiol. 34:1633-1636.
17. Pujol, F. H., C. L. Loureiro, M. Devesa, L. Blitz, K. Parra, S. Beker, and F. Liprandi. 1997. Determination of genotypes of hepatitis C virus from Venezuelan isolates by restriction fragment length polymorphism. J. Clin. Microbiol. 35:1870-1872.
18. Roggendorf, M., M. Lu, H. Meisel, M. Riffelmann, E. Schreier, and S. Viazov. 1996. Rational use of diagnostic tools in hepatitis C. J. Hepatol. 24(Suppl. 2):26-34.
19. Sällberg, M., U. Rudén, B. Wahren, and L. O. Magnius. 1992. Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: the isotypes and the recognition site. Immunol. Lett. 33:27-34.
20. Sällberg, M., U. Rudén, B. Wahren, and L. O. Magnius. 1993. Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site within the envelope 1 protein. Clin. Exp. Immunol. 91:489-494.
21. Sato, A., Y. Sho, H. Nakamura, T. Kunitomo, and T. Arima. 1994. Immune response of blood donors to peptides of various lengths and those with genotypic sequence variations corresponding to the N-terminal portion of the core protein of hepatitis C virus. J. Med. Virol. 44:88-91.
22. Siemoneit, K., M. da Silva Cardoso, A. Wolpl, S. Epple, H. Wintersinger, K. Koerner, and B. Kubanek. 1994. Isotype-specific immune response to a single hepatitis C virus core epitope defined by a human monoclonal antibody: diagnostic value and correlation to PCR. Ann. Hematol. 69:129-133.
23. Tobler, L. H., M. Busch, J. Peterson, R. Kochesky, C. Bahl, and S. R. Lee. 1996. Identification of a crossreactive epitope within hepatitis C virus core antigen: resolution by third-generation hepatitis C virus assays. Transfusion 36:581-582.
24. Wienhues, U., H.-G. Ihlenfeldt, C. Seidel, U. Schmitt, W. Kraas, and G. Jung. 1998. Characterization of a linear epitope in the nonstructural region 4 of hepatitis C virus with reactivity to seroconversion antibodies. Virology 245:281-288.
25. Zhang, Z.-X., M. Chen, C. Hultgren, A. Birkett, D. R. Milich, and M. Sällberg. 1997. Immune responses to the hepatitis C virus NS4A protein are profoundly influenced by the combination of the viral genotype and the host major histocompatibility complex. J. Gen. Virol. 78:2735-2746.